missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Neogenin Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA555695
This item is not returnable.
View return policy
Description
Immunogen sequence: SVNGSHKYKG NSKDVKPPDL WIHHERLELK PIDKSPDPNP IMTDTPIPRN SQDITPVDNS MDSNIHQRRN SYRGHESEDS MSTLAGR Highest antigen sequence identity to the following orthologs: Mouse - 98%, Rat - 98%.
The protein encoded by this gene mediates transcriptional control by interaction with the activation function 2 (AF2) region of several nuclear receptors, including the estrogen, retinoic acid, and vitamin D3 receptors. The protein localizes to nuclear bodies and is thought to associate with chromatin and heterochromatin-associated factors. The protein is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains - a RING, a B-box type 1 and a B-box type 2 - and a coiled-coil region. Two alternatively spliced transcript variants encoding different isoforms have been described for this gene.
Specifications
| Neogenin | |
| Polyclonal | |
| Unconjugated | |
| Neo1 | |
| 2610028H22Rik; AI327052; D930014N22Rik; HsT17534; IGDCC2; immunoglobulin superfamily DCC subclass member 2; NEO; Neo1; Neogenin; neogenin 1; neogenin homolog 1; NGN; NGNDKFZp547A066; NTN1R2 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 4756 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 0.2 mg/mL | |
| PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
| Q92859 | |
| Neo1 | |
| Recombinant protein corresponding to Human Neogenin. Recombinant protein control fragment (Product #RP-95257). | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction